National Health Investors, Inc. (NHI) Institutional Ownership & Insider Trading

303 institutions reported holding National Health Investors, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 2 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

NHINational Health Investors, Inc.Follow NHI — free

REIT - Healthcare Facilities · Real Estate

—

Price chart with a free account

Market cap: 3.3B
P/E TTM: 19.4
Dividend yield: 5.5%
52-week: —
Next earnings: 9 Nov, in 16 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

303 institutions held 77.7% of the shares. Across filers that reported both quarters, shares held changed +10.0%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	303	38	+10.0%	107	34	83	48
Mar 26	316	34	+3.3%	103	40	84	18
Dec 25	290	34	-7.6%	102	24	69	23
Sep 25	278	35	+4.1%	100	23	80	20
Jun 25	272	35	+9.1%	119	22	57	24
Mar 25	277	31	+2.3%	93	35	84	21
Dec 24	270	31	+2.9%	102	23	74	31
Sep 24	274	29	+10.1%	68	60	76	12

National Health Investors, Inc. — questions

Who owns National Health Investors, Inc. stock?: 303 institutions reported National Health Investors, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (17.8%), VANGUARD PORTFOLIO MANAGEMENT LLC (9.4%), STATE STREET CORP (5.6%).
Are National Health Investors, Inc. insiders buying or selling?: 2 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from National Health Investors, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.